PTPN1 and breast carcinoma: Comparing the inhibitory effect of tested compounds against PTP1B enzymatic activity and MCF-7 viability presented as IC50 values (Table 1), we can conclude that epigallocatechin is the most effective inhibitor from tested compounds both oncogenic PTP1B phosphatase and breast cancer cell viability.